One-third of diabetes patients with hyperkalaemia during acute admission have reninaldosterone angiotensin system (RAAS) antagonists discontinued by hospital discharge

Hugh Logan Ellis¹ , Claire Sharpe¹ , Philip Kelly¹ , Mohammad Al-Agil¹ , Anthony Shek² , James Teo¹ , Martin Whyte¹

1 King’s College Hospital, London UK
2 King’s College London, London UK